MedPage Today on MSN
'Immediately Practice-Changing' Lung Cancer Trial in Curative Setting
Substantial EFS improvement with selpercatinib in RET fusion-positive disease ...
Radiation therapy is a treatment that uses high-energy rays, like X-rays, gamma rays or protons, to target and destroy cancer cells. It works by damaging the DNA of cancer cells, preventing them from ...
Progressive pulmonary fibrosis was independently associated with worse progression-free survival and overall survival.
An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of radiation treatments in preclinical models, according to a study by UT ...
Combining TRT with EGFR-TKIs significantly improves PFS and OS in EGFR-mutated oligo-organ metastatic NSCLC patients compared to EGFR-TKIs alone. The study suggests personalized treatment approaches, ...
InvestorsHub on MSN
Lilly reports strong phase 3 results for Retevmo in early-stage lung cancer (LLY)
Eli Lilly and Company (NYSE:LLY) announced positive data from its Phase 3 LIBRETTO-432 trial, showing that Retevmo significantly lowered the risk of disease recurrence or death in patients with ...
Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy without increasing the risk of severe lung inflammation (pneumonitis). This is ...
Higher radiation doses (70 Gy) in lung cancer treatment did not increase pneumonitis risk and improved survival rates. Patients receiving 70 Gy had lower pneumonitis rates (34.5%) compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results